The Third International Summit on Genome Editing concluded Monday with ethicists warning scientists to slow down efforts to use gene-editing to enhance the health of embryos.
Some doctors and medical practices voluntarily give rebates on a bill if an injury occurs during a procedure, while others will not, a medical ethicist says. Here's how patients can respond.
Health and Human Services Secretary Xavier Becerra is reversing restrictions on the use of fetal tissue in medical research implemented under former President Trump.
These structures made from living human cells are similar to human embryos at the stage when they implant in the womb. They allow scientists to research new ways to treat infertility.
Aiming to find a cheaper, easier way than IVF to ensure human embryos are healthy before implantation, researchers paid women to be inseminated, then flushed the embryos from their wombs for analysis.
The consumer advocacy group Public Citizen also says the multicenter study of life-threatening sepsis will at best produce confusing results. A Harvard doctor and designer of the research disagrees.
A woman who received a uterus transplant recently delivered a healthy baby boy. NPR's Mary Louise Kelly talks with the doctors working on the experiment about its ethics, risk, and cost implications.
NPR gets exclusive access to a lab in Portland, Ore., where scientists have begun editing the DNA in human embryos to try to prevent genetic diseases.
An advisory panel to the Food and Drug Administration recommends the agency, for the first time, approve a new kind of treatment that uses genetically modified immune cells to attack cancer cells.